| Literature DB >> 30240153 |
Andrew Blease1, Patricia Das Neves Borges2, Marcia Curtinha3, Behzad Javaheri4, Isabell S von Loga3, Ida Parisi3, Jadwiga Zarebska3, Andrew Pitsillides4, Tonia L Vincent3, Paul K Potter1.
Abstract
With the increasing availability and complexity of mouse models of disease, either spontaneous or induced, there is a concomitant increase in their use in the analysis of pathogenesis. Among such diseases is osteoarthritis, a debilitating disease with few treatment options. While advances in our understanding of the pathogenesis of osteoarthritis has advanced through clinical investigations and genome-wide association studies, there is still a large gap in our knowledge, hindering advances in therapy. Patient samples are available ex vivo, but these are generally in the very late stages of disease. However, with mice, we are able to induce disease at a defined time and track the progression in vivo and ex vivo, from inception to end stage, to delineate the processes involved in disease development.Entities:
Keywords: DMM; destabilized medial meniscus; histology; mouse models; osteoarthritis; μCT
Mesh:
Year: 2018 PMID: 30240153 DOI: 10.1002/cpmo.50
Source DB: PubMed Journal: Curr Protoc Mouse Biol ISSN: 2161-2617